Litigation for buprenorphine hydrochloride; naloxone hydrochloride

US Court Litigation for buprenorphine hydrochloride; naloxone hydrochloride

Patent	Case Name	Docket	Date Filed	Date Terminated	Cause	Court	Jury Demand	Link To Docket
10,874,661		3:20-cv-12588|D.N.J.	2020-09-11	2023-07-20	35:271 Patent Infringement	District Court, D. New Jersey
10,946,010		3:20-cv-12588|D.N.J.	2020-09-11	2023-07-20	35:271 Patent Infringement	District Court, D. New Jersey
11,020,387		3:20-cv-12588|D.N.J.	2020-09-11	2023-07-20	35:271 Patent Infringement	District Court, D. New Jersey
11,020,388		3:20-cv-12588|D.N.J.	2020-09-11	2023-07-20	35:271 Patent Infringement	District Court, D. New Jersey
11,020,388		5:11-cv-01846|N.D. Cal.	2011-04-15	2018-06-27	15:1125 Trademark Infringement (Lanham Act)	District Court, N.D. California	Both
6,159,498	BioDelivery Sciences International, Inc. v. Alvogen Pb Research & Development LLC	1:18-cv-01395|D. Del.	2018-09-07	2022-01-21	35:271 Patent Infringement	District Court, D. Delaware	None

Patent Trial and Appeal Board Cases for buprenorphine hydrochloride; naloxone hydrochloride

Patent	Petitioner	Status	Filing Date	Accorded Filing Date	Patent Owner	Trial Type	Trial Number	Decision Date	Inventor	Document Download
7,579,019	MONOSOL RX, LLC		2014-01-22	01-22-2014	Arius Two, Inc.	Inter partes review		08-06-2014	Gilles Tapolsky
8,017,150	Teva Parmaceuticals USA Inc.		2015-12-04	12-04-2015	MONOSOL RX, LLC	Inter partes review		05-23-2016	Robert Yang
8,017,150	Dr. Reddy’s Laboratories, Inc. et al.		2016-05-31	05-31-2016	MonoSol Rx, LLC	Inter partes review		12-05-2016	Robert Yang
8,475,832	BioDelivery Sciences International, Inc.		2014-01-15	01-15-2014	RB Pharmaceuticals Limited	Inter partes review		07-29-2014	Garry Myers
8,475,832	BioDelivery Sciences International, Inc.		2014-06-20	06-20-2014	RB Pharmaceuticals Limited	Inter partes review		12-19-2014	Garry Myers
8,475,832	Teva Pharmaceuticals USA, Inc.		2015-12-03	12-03-2015	Indivior UK Limited	Inter partes review		06-10-2016	Garry Myers